p: (=Effect) 는 표준식으로 log2 fold-change after adjusting for the covariate effects on the outcome”.
Psychosis in PD
pipeline
| Target | mechanism | Design | results |
|---|---|---|---|
| Nuplazid (pimavanserin) by Acadia |
- approved by the FDA for the treatment of hallucinations and delusions associated with PD psychosis - an inverse agonist and antagonist at serotonin 5-HT2A receptors with high binding affinity (Ki 0.087 nM) and at serotonin 5-HT2C receptors with lower binding affinity (Ki 0.44 nM). Acadia developed (?)/used a new scale called Scale for the Assessment of Positive Symptoms-Hallucinations and Delusions (SAPS-H+D), (Acadia modified the clinical score such as deletion of synptom that pimavanserin didn't work on) |
Radiochemical
| radioactivity | specific activity (Ci/mmol) | tSIS, | CPM: Counts per minute. | Efficiency | DPM (AK For binding I use DPM typically) | Concentration - fmol/mg | Concentration - molarity | |||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Curies per millimole (Ci/mmol) 1 Ci equals 2.22 × 10¹² dpm (disintegrations per minute) AK: 2220000dpm = 1 uci |
the amount of radiolabeled mass in a sample, Ci/mmol or Ci/mg. For example, 33P-gamma-ATP has a specific activity of 3000 Ci/mmol (on the calibration date). These units indicate that there are 3000 Curies per millimole of ATP |
Transformed spectral index of the sample, (?) Quench correction methods In all liquid scintillation counting, there is some degree of reduction of efficiency of counting due to an interference with energy transfer processes leading to the production of a photon or to absorption of the photon by coloured or other light-absorbing substances present.s |
CPM provides for the exact quantity of those atoms that have actually decayed. CPM: Quenched sample count rates |
This value will be based on the type of radiation detector being used and the energy of the radioactive isotopes. Efficiency is a parameter measured as part of IPA (Instrument Performance Assessment) -Efficiency is the fraction of the radioactive disintegration that are detected by the counter. -With 3H, counting efficiency is much lower (maximally ca. 60%) |
DPM merely measures the number of atoms that decay in one minute given a select amount of radioactive material. DPM: absolute activity 2220000dpm = 1 uci |
[Homogenate binding assay] fmol/mg = fmole radioligand bound per mg of protein (One fmol is 10⁻¹⁵ mol.) 분모가 i) homogenate 실험의 경우는 바로 protein의 mg일 것. Convert from cpm to fmol/mg using the amount of protein in each tube (0.01 mg), the efficiency of the counting (90%), and the specific radioactivity of the ligand (2190 Ci/mmol). fmol/mg = cpm / (2.22 × 10¹² dpm Ci × 0.90 cpm/dpm × 2190 Ci mmol × 10⁻¹² mmol/fmol × 0.01 mg) Good resource: 'Analyzing Binding Data' |
[Homogenate assay] Assumptions: - the brain density around 1 g wet weight; assumes ~1 mg of protein per mg of wet weight -1 fmol/mg of protein 으로 be approximated 0.1 fmol/mg of wet tissue. [ARG] (2008 Patel) Assumption for ARG study: there is 50 mg of protein per g of brain tissue. So, 100 fmol/mg protein 은 5 nM. (This conversion factor is only valid for brain) 근데 위의 assumption 이해 안 감. saturation binding (only HC)에서 AK가 계산한 Kd를 써서 nM로 바꾼듯 한데. | |||||||||||||||||||||||||||||||||||||||||||||||||
| e g | tSIS value: a parameter to monitor for the color quench level of samples, | 22,000 | 22% |
DPM = CPM / Efficiency DPMs = 22,000 / .22 = 100,000. This means that given a measurement of 22,000 CPMs as per a 22% efficiency rating, this measurement is equivalent to 100,000 DPMs. | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| I'm assuming they're still using the tSIS error to calculate DPM? If you could ask TNTechnos for their normalization file for tritium and their IPA | I'm assuming they're still using the microβ platereader?). | TNT are still using the tSIS error to calculate DPM? If you could ask TNTechnos for their normalization file for tritium and their IPA | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| When a radioactive decay event occurs in an LSC cocktail → Scintillator (a type of phosphor) emit fluorescence when exposed to radiation such as X-rays and gamma rays. The molecules of the fluors/scintillator dissolved in the solvent absorb the energy released by the solvent and re-emit this energy (at a higher wavelength) as visible light of wavelength around 420 nm | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Definitions
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Rare Disease
| Population | |||
|---|---|---|---|
| sPD | 1mil in US | 3 억 (US population) 0.3% (NLRP3 EPOP) 즉 3/1,000 | |
| 1 | 300 | ||
| GBA-PD | US: 1 Mil의 10% → 100,000 (200,000보다 적으니 rare disease이긴 하네) | ||
| CMT1 | 1 | 2,500 | |
| AGS | 1-5 | 10,000 orpha.net/consor/cgi-bin/OC_Exp.php?Expert=51&lng=EN | |
| FTLD-Tau | 1 | 20,000 5-7 per 100,000 {Bahia, 2013 #21}: 위와 유사해야 하는데, Daria: 10-20/100,000 (theoretical genetic prevalence of biallelic ...) |
(Page footer table continues onto next photo with Terminology columns “in general population” / “with symptomatic PD” / “mutations with symptomatic PD” — United States and Europe 23,000-70,000 / 1,622-13,000 / 33,000-45,000; United States 10,000-30,000 / 930-7,400 / 19,000-26,000.)
Uncertain Spans
| location | transcription | uncertainty |
|---|---|---|
| ARG concentration cell | 1 fmol/mg of protein 으로 be approximated 0.1 fmol/mg of wet tissue | Mixed Korean/English fragment with non-standard “be approximated” verb form; preserved as written. |